Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Plasma vitamin K concentrations depend on CYP4F2 polymorphism and influence on anticoagulation in Japanese patients with warfarin therapy.

Hirai K, Yamada Y, Hayashi H, Tanaka M, Izumiya K, Suzuki M, Yoshizawa M, Moriwaki H, Akimoto T, Tsuji D, Inoue K, Itoh K.

Thromb Res. 2015 May;135(5):861-6. doi: 10.1016/j.thromres.2015.02.019. Epub 2015 Feb 27.

PMID:
25747538
2.

Intentional overdose of warfarin in an adult: anticoagulant reversal in the ED.

Matthews SS, Ringeisen AL, Wedro B.

Am J Emerg Med. 2014 Sep;32(9):1150.e1-2. doi: 10.1016/j.ajem.2014.02.025. Epub 2014 Feb 25. No abstract available.

PMID:
24674108
3.

Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trial.

Majeed H, Rodger M, Forgie M, Carrier M, Taljaard M, Scarvelis D, Gonsalves C, Rodriguez RA, Wells PS.

Thromb Res. 2013 Sep;132(3):329-35. doi: 10.1016/j.thromres.2013.07.019. Epub 2013 Jul 29.

PMID:
23953594
4.

Pharmacologic interventions for reversing the effects of oral anticoagulants.

Kalus JS.

Am J Health Syst Pharm. 2013 May 15;70(10 Suppl 1):S12-21. doi: 10.2146/ajhp130041.

PMID:
23640528
5.

An update of consensus guidelines for warfarin reversal.

Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH).

Med J Aust. 2013 Mar 4;198(4):198-9.

PMID:
23451962
6.

Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort study.

Bejarano-Achache I, Levy L, Mlynarsky L, Bialer M, Muszkat M, Caraco Y.

Clin Ther. 2012 Apr;34(4):811-23. doi: 10.1016/j.clinthera.2012.02.009. Epub 2012 Mar 13.

PMID:
22417713
7.

Treatment of warfarin-associated coagulopathy with vitamin K.

Patriquin C, Crowther M.

Expert Rev Hematol. 2011 Dec;4(6):657-65; quiz 666-7. doi: 10.1586/ehm.11.59. Review.

PMID:
22077529
8.

Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.

Clark TR, Burns S.

Am J Health Syst Pharm. 2011 Sep 1;68(17):1603-5. doi: 10.2146/ajhp100681.

PMID:
21856805
9.

Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.

Lee R, Wen A, Berube C.

Am J Health Syst Pharm. 2011 May 1;68(9):814-7. doi: 10.2146/ajhp100159.

PMID:
21515865
10.

Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.

Davies BE, Aceves Baldó P, Lennon-Chrimes S, Brewster M.

Br J Clin Pharmacol. 2010 Dec;70(6):834-43. doi: 10.1111/j.1365-2125.2010.03780.x.

11.

Interaction between warfarin and the herbal product Shengmai-yin: a case report of intracerebral hematoma.

Su Q, Li Y.

Yonsei Med J. 2010 Sep;51(5):793-6. doi: 10.3349/ymj.2010.51.5.793.

12.

An audit of the role of vitamin K in the reversal of International Normalised Ratio (INR) in patients undergoing surgery for hip fracture.

Bhatia M, Talawadekar G, Parihar S, Smith A.

Ann R Coll Surg Engl. 2010 Sep;92(6):473-6. doi: 10.1308/003588410X12664192075774. Epub 2010 May 19.

13.

Small intestinal bacterial overgrowth and warfarin dose requirement variability.

Giuliano V, Bassotti G, Mourvaki E, Castellani D, Filippucci E, Sabatino G, Gizzi S, Palmerini F, Galli F, Morelli O, Baldoni M, Morelli A, Iorio A.

Thromb Res. 2010 Jul;126(1):12-7. doi: 10.1016/j.thromres.2009.11.032. Epub 2010 Jan 3.

PMID:
20051286
14.

Life-threatening retroperitoneal bleeding due to warfarin-drug interactions.

Chan TY.

Pharmacoepidemiol Drug Saf. 2009 May;18(5):420-2. doi: 10.1002/pds.1729.

PMID:
19283775
15.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
16.

An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.

Denas G, Cucchini U, Iliceto S, Pengo V.

Thromb Haemost. 2009 Feb;101(2):410-1. No abstract available.

PMID:
19190831
17.

[Vitamin K epoxide reductase complex 1 gene polymorphism and warfarin dose requirement in Chinese patients].

Jiang NX, Song J, Xu B.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Jul;35(7):652-4. Chinese.

PMID:
17961434
18.

Comparison of various phytonadione (vitamin K1) administration routes in achieving warfarin reversal.

Laible B.

S D Med. 2007 Apr;60(4):158-9. No abstract available.

PMID:
17555152
19.

Relationship between diet and anticoagulant response to warfarin: a factor analysis.

Custódio das Dôres SM, Booth SL, Martini LA, de Carvalho Gouvêa VH, Padovani CR, de Abreu Maffei FH, Campana AO, Rupp de Paiva SA.

Eur J Nutr. 2007 Apr;46(3):147-54. Epub 2007 Mar 13. Erratum in: Eur J Nutr. 2007 Jun;46(4):243. Aújo Martini, Ligia [corrected to Martini, Ligia Araújo].

PMID:
17356795
20.

Reversal of asymptomatic over-anticoagulation with oral vitamin K.

Chirputkar SK, Poole HJ, McNeil RC, Tansey P, Etherington AM, Morrison C, Tait RC.

Br J Haematol. 2006 Nov;135(4):591-2. No abstract available.

PMID:
17054668
Items per page

Supplemental Content

Loading ...
Write to the Help Desk